Literature DB >> 23529661

[Antiarrhythmic agents].

Ursula Ravens1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23529661     DOI： 10.1007/s00399-013-0254-x

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


× No keyword cloud information.
  4 in total

1.  The long and short of antiarrhythmic drug treatment.

Authors:  A John Camm; Irene Savelieva
Journal:  Lancet       Date:  2012-06-18       Impact factor: 79.321

2.  Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.

Authors:  Paulus Kirchhof; Dietrich Andresen; Ralph Bosch; Martin Borggrefe; Thomas Meinertz; Ulli Parade; Ursula Ravens; Alexander Samol; Gerhard Steinbeck; Andras Treszl; Karl Wegscheider; Günter Breithardt
Journal:  Lancet       Date:  2012-06-18       Impact factor: 79.321

Review 3.  Electrical, contractile and structural remodeling during atrial fibrillation.

Authors:  Maurits Allessie; Jannie Ausma; Ulrich Schotten
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

Review 4.  Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.

Authors:  Etienne Aliot; Alessandro Capucci; Harry J Crijns; Andreas Goette; Juan Tamargo
Journal:  Europace       Date:  2010-12-07       Impact factor: 5.214
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.